Efficacy News and Research

RSS
Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Etanercept no better than prednisone for COPD exacerbations

Etanercept no better than prednisone for COPD exacerbations

Melatonin viable alternative for REM sleep behavior disorder treatment

Melatonin viable alternative for REM sleep behavior disorder treatment

Glimmer of hope for imatinib-resistant GIST

Glimmer of hope for imatinib-resistant GIST

First new TB vaccine in century fails initial testing

First new TB vaccine in century fails initial testing

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

FluGen's REDEE FLU vaccine protects against both H5N1 and H3N2 strains

FDA approves Cardiva Medical's VASCADE Vascular Closure System

FDA approves Cardiva Medical's VASCADE Vascular Closure System

Steroid injections not advisable for tennis elbow

Steroid injections not advisable for tennis elbow

Selective laser trabeculoplasty promising for glaucoma

Selective laser trabeculoplasty promising for glaucoma

Emotion regulation therapy benefits bipolar patients

Emotion regulation therapy benefits bipolar patients

Experimental TB vaccine does not protect infants, study shows

Experimental TB vaccine does not protect infants, study shows

Elan agrees to restructure Tysabri collaboration with Biogen Idec

Elan agrees to restructure Tysabri collaboration with Biogen Idec

BSD Medical announces results from BSD-2000 hyperthermia system study on pancreatic cancer

BSD Medical announces results from BSD-2000 hyperthermia system study on pancreatic cancer

Ramipril may improve pain-free walking among patients with PAD and intermittent claudication

Ramipril may improve pain-free walking among patients with PAD and intermittent claudication

Verastem commences VS-6063 plus paclitaxel Phase 1/1b trial in advanced ovarian cancer

Verastem commences VS-6063 plus paclitaxel Phase 1/1b trial in advanced ovarian cancer

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Viral conjunctivitis: potential new treatment

Viral conjunctivitis: potential new treatment

Detection of B cells may predict graft-versus-host disease

Detection of B cells may predict graft-versus-host disease

GLP-1 receptor agonists associated with reduced BMI in adolescents with severe obesity

GLP-1 receptor agonists associated with reduced BMI in adolescents with severe obesity

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.